Pergolide mesylate: Adverse events occurring in the treatment of cocaine dependence

American Journal on Addictions

Volumn 6, Issue 2, 1997, Pages 117-123

  Malcolm, Robert ^a,b   Moore, Juliann W ^a   Kajdasz, Daniel K ^a   Cochrane, Carolyn E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DOPAMINE; PERGOLIDE MESILATE; VALPROIC ACID;

ABUSE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOUBLE BLIND PROCEDURE; FEMALE; HEART BLOCK; HUMAN; MALE; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SUBSTANCE ABUSE; THORAX PAIN; WITHDRAWAL SYNDROME; WOLFF PARKINSON WHITE SYNDROME;

EID: 0030995394     PISSN: 10550496     EISSN: None     Source Type: Journal    
DOI: 10.3109/10550499709137022     Document Type: Article

References (17)

1. Withers NW, Pulvirinti L, Koob GF, et al: Cocaine abuse and dependence. J Clin Psychopharmacology 1995; 15:63-78
2. Ritz MC, Kuhar MJ: Psychostimulant drugs and a dopamine hypothesis regarding addiction: update on recent research. Biochem Soc Symp 1993; 59:51-64
3. Schuckit MA: The treatment of stimulant dependence. Addiction 1994; 89:1559-1564
4. Gawin FH, Kleber HD, Byck R, et al: Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 1989; 46:117-121
5. Halikas J, Crosby R, Carlson G, et al: Cocaine reduction in non-motivated crack users using carbamazepine vs. placebo in a short-term, double-blind, crossover design. Clin Pharmacol Ther 1991; 50:81-95
6. Gawin FH, Allen D, Humblestone B: Outpatient treatment of "crack" cocaine smoking with flupentixol decanoate: a preliminary report. Arch Gen Psychiatry 1989; 46:322-325
7. Tennant FS, Sagherian AA: Double-blind evaluation of amantadine on cocaine craving. Arch Intern Med 1987; 147:100-112
8. Gawin FH, Morgan C, Kosten TR: Double-blind evaluation of the effect of acute amantadine on cocaine craving. Psychopharmacology 1989; 97:402-403
9. Dackis CA, Gold MS, Sweeney DR, et al: Single-dose bromocriptine reverses cocaine craving. Psychiatry Res 1987; 20:261-264
10. Preston KL, Sullivan JT, Strain EC, et al: Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers. J Pharmacol Exp Ther 1992; 262:279-291
11. Weddington WW: Use of unproven and unapproved drugs to treat cocaine addiction (letter). Am J Psychiatry 1990; 147:1576
12. Langtry HD, Clissold SP: Pergolide: a review of its pharmacologic properties and therapeutic potential in Parkinson's disease. Drugs 1990; 349:419-506
13. Malcolm RJ, Hutto BR, Phillips JD, et al: Pergolide treatment of cocaine withdrawal. J Clin Psychiatry 1991; 52:39-40
14. Leibowitz M, Lieberman A, Goldstein M, et al: Cardiac effects of pergolide. Clin Pharmacol Ther 1981; 30:718-723
15. Lange AE, Quinn N, Marsden CD, et al: Pergolide in late-stage Parkinson's disease. Ann Neurol 1982; 12:243-247
16. Kurlan R, Miller C, Levy R, et al: Double-blind assessment of potential pergolide-induced cardiotoxicity. Neurology 1986; 36:993-995
17. Factor SA, Sanchez-Ramos JR, Weiner WJ: Parkinson disease: an open-label trial of pergolide in patients failing bromocriptine. J Neurol Neurosurg Psychiatry 1988; 51:529-533